MedTrace Logo

Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion

NCT05477147 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2025-12-09

No results posted yet for this study

Summary

Multi-center, international, non-randomized clinical trial evaluating the use of Volta's VX1 algorithm as used in combination with repeat catheter ablation after AF recurrence after previous catheter ablation.

Conditions

Interventions

DEVICE

Catheter Ablation

Cardiac catheter ablation for recurrent AF after previous ablation (catheter or surgical).

Sponsors & Collaborators

  • Volta Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-17
Primary Completion
2025-05-07
Completion
2025-09-30
FDA Device
Yes

Countries

  • United States
  • Belgium
  • France
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05477147 on ClinicalTrials.gov